Patterns of Hematologic Function and Cytokine Release Syndrome Severity in ALL Patients Receiving CAR-T and TCR-T Therapies Using Pooled Clinical Trial Data

被引:0
|
作者
Agarwal, Vibhu [1 ]
Socolov, Alexandru [1 ]
Buderi, Robert [1 ]
Rusli, Emelly [1 ]
Bouzit, Lilia [1 ]
Talwai, Aniketh [1 ]
Itzkovich, Yahav [1 ]
Galaznik, Aaron [1 ]
Aptekar, Jacob [1 ]
机构
[1] Dassault Systemes Co, Medidata Acorn AI, New York, NY 10017 USA
关键词
D O I
10.1182/blood-2021-149180
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4826
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Easix Predicts Severe Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neuro-Toxicity Syndrome (ICANS) in Patients Receiving CD19Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy
    Korell, Felix
    Penack, Olaf
    Schmitt, Michael
    Mueller-Tidow, Carsten
    Bullinger, Lars
    Dreger, Peter
    Luft, Thomas
    BLOOD, 2021, 138 : 3861 - +
  • [32] MVP Combined with FC As Lymphocyte-Depleting Chemotherapy before CAR-T Treatment Can Reduce the Incidence of Severe Cytokine Release Syndrome for Relapsed/Refractory ALL Patients with High Tumour Burden
    Tang, XiaoWen
    Li, Zheng
    Xu, Ting
    Dai, Haiping
    Yin, Jia
    Tian, Xiaopeng
    Xue, Shengli
    Xu, Yang
    Zhu, Xiaming
    Kang, Liqing
    Xia, Yujie
    Yu, Lei
    Wu, Depei
    BLOOD, 2017, 130
  • [33] An Economic Model to Estimate Costs of Cytokine Release Syndrome and Neurological Events Among Patients Treated with CAR T Cell Therapies for Relapsed or Refractory Follicular Lymphoma
    Saunders, Ashley C.
    Badaracco, Jack
    BLOOD, 2023, 142
  • [34] A Multi-Omic Single-Cell Landscape of Cytokine Release Syndrome in Multiple Myeloma Patients after Anti-BCMA CAR-T Cell Therapy
    Hu, Yongxian
    Li, Xia
    Jiang, Penglei
    Yang, Tingting
    Gu, Tianning
    Si, Xiaohui
    Xie, Yali
    Zhang, Mingming
    Wei, Guoqing
    Xu, Huijun
    Cen, Zenan
    Cui, Jiazhen
    Huang, Simao
    Ni, Fang
    Wang, Linqin
    Wang, Xiujian
    Zeng, Xiangjun
    Kong, Delin
    Zhao, Houli
    Chang, Alex H.
    Zhang, Yanlei
    Zhang, Jin
    Huang, Jinyan
    Qian, Pengxu
    Huang, He
    BLOOD, 2023, 142
  • [35] Plasma Microbial Cell-Free DNA to Characterize Infection Vs Cytokine Release Syndrome in Pediatric Patients with B ALL after CAR T Cell Therapy
    Aftandilian, Catherine
    Bito, Xue Rachel
    Berman, David M.
    Duttagupta, Radha
    Davis, Kara L.
    BLOOD, 2022, 140 : 4681 - 4683
  • [36] Brain metabolic correlates of Cytokine Release Syndrome and Immune effector cell-associated neurotoxicity in patients with Diffuse Large B-Cell Lymphoma (DLCBL) treated with CAR-T
    Di Raimondo, T.
    Gambella, M.
    Raiola, A.
    D'Amico, F.
    Sofia, L.
    Lanfranchi, F.
    Ghiggi, C.
    Lapucci, C.
    Sambuceti, G.
    Bauckneht, M.
    Inglese, M.
    Angelucci, E.
    Morbelli, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S22 - S23
  • [37] Endothelial Activation and Stress Index Score as a Prognostic Factor of Cytokine Release Syndrome in CAR-T Patients - A Retrospective Analysis of Multiple Myeloma and Large B-Cell Lymphoma Cohorts
    Tomasik, Jaromir
    Avni, Batia
    Grisariu, Sigal
    Elias, Shlomo
    Zimran, Eran
    Stepensky, Polina
    Basak, Grzegorz W.
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2024, 72 (01)
  • [38] The Dual PI3Kδγ Inhibitor Duvelisib Potently Inhibits IL-6 Production and Cytokine Release Syndrome (CRS) While Maintaining CAR-T Function in Vitro and In Vivo
    Amatya, Parmeshwar N.
    Carter, Alun J.
    Ritchey, Julie K.
    Niswonger, Jessica
    Cooper, Matthew L.
    Pachter, Jonathan A.
    DiPersio, John F.
    BLOOD, 2020, 136
  • [39] Individual Patient Data Meta-Analysis from 16 Trials for Safety Factors in Cytokine Release Syndrome After CAR-T Therapy in Patients with Non-Hodgkin Lymphoma (NHL) and Acute Lymphoblastic Leukemia
    Jie Li
    Zhenyu Wu
    Naiqing Zhao
    Advances in Therapy, 2019, 36 : 2881 - 2894
  • [40] Individual Patient Data Meta-Analysis from 16 Trials for Safety Factors in Cytokine Release Syndrome After CAR-T Therapy in Patients with Non-Hodgkin Lymphoma (NHL) and Acute Lymphoblastic Leukemia
    Li, Jie
    Wu, Zhenyu
    Zhao, Naiqing
    ADVANCES IN THERAPY, 2019, 36 (10) : 2881 - 2894